This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Condos, R.
Right arrow Articles by Pine, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Condos, R.
Right arrow Articles by Pine, R.

 Previous Article  |  Next Article 

Infection and Immunity, April 2003, p. 2058-2064, Vol. 71, No. 4
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.4.2058-2064.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Recombinant Gamma Interferon Stimulates Signal Transduction and Gene Expression in Alveolar Macrophages In Vitro and in Tuberculosis Patients

Rany Condos,1 Bindu Raju,1 Antony Canova,2 Ben-Yang Zhao,2,{dagger} Michael Weiden,1 William N. Rom,1,3 and Richard Pine2*

Bellevue Chest Service and Division of Pulmonary and Critical Care Medicine, Departments of Medicine,1 Environmental Medicine, NYU School of Medicine, New York, New York 10016,3 Public Health Research Institute, Newark, New Jersey 071032

Received 28 May 2002/ Returned for modification 16 July 2002/ Accepted 12 December 2002

Tuberculosis is the seventh leading cause of morbidity and mortality in the world, with eight million cases per year. Animal and human studies demonstrate an enrichment of CD4 cells at sites of disease, with a more favorable clinical course when there is a Th1 response with the presence of gamma interferon (IFN-{gamma}). We previously treated patients who had multidrug-resistant tuberculosis with recombinant IFN-{gamma} (rIFN-{gamma}) in aerosol form and were able to convert smear-positive cases to smear negative with 12 treatments over 1 month. We hypothesized that rIFN-{gamma} would induce signal transducer and activator of transcription (STAT) and interferon regulatory factor (IRF) binding activity in alveolar macrophages (AM). AM treated in vitro showed clear upregulation of STAT-1 and IRF-1 by rIFN-{gamma}. STAT-1 was not activated and IRF-1 was only weakly induced after 1 day of infection by Mycobacterium tuberculosis TN913. In bronchoalveolar lavage (BAL) cells obtained from 10 of 10 tuberculosis patients 10 ± 2 days post-antituberculosis treatment, there was no detectable STAT-1 or IRF-1 DNA-binding activity. After 4 weeks of treatment with rIFN-{gamma} aerosol in addition to the antituberculosis drugs, 10 of 10 patients had increased STAT-1, IRF-1, and/or IRF-9 DNA-binding activity in BAL cells from lung segments shown radiographically to be involved and in those shown to be uninvolved. Symptoms and chest radiographs improved, and amounts of macrophage inflammatory cytokines and human immunodeficiency virus type 1 (HIV-1) viral loads (in five of five HIV-1-coinfected patients) declined in the second BAL specimens. rIFN-{gamma} aerosol induces signal transduction and gene expression in BAL cells and should be evaluated for efficacy in a randomized, controlled clinical trial.


* Corresponding author. Mailing address: Public Health Research Institute, 225 Warren St., Newark, NJ 07103. Phone: (973) 854-3320. Fax: (973) 854-3321. E-mail: rpine{at}phri.org.

Editor: S. H. E. Kaufmann

{dagger} Present address: New York City Department of Health, Bureau of Laboratories, New York, NY 10016.


Infection and Immunity, April 2003, p. 2058-2064, Vol. 71, No. 4
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.4.2058-2064.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Curtis, J. L., Freeman, C. M., Hogg, J. C. (2007). The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research. Proc Am Thorac Soc 4: 512-521 [Abstract] [Full Text]  
  • Tanaka, N., Hoshino, Y., Gold, J., Hoshino, S., Martiniuk, F., Kurata, T., Pine, R., Levy, D., Rom, W. N., Weiden, M. (2005). Interleukin-10 Induces Inhibitory C/EBP{beta} through STAT-3 and Represses HIV-1 Transcription in Macrophages. Am. J. Respir. Cell Mol. Bio. 33: 406-411 [Abstract] [Full Text]  
  • Punturieri, A., Alviani, R. S., Polak, T., Copper, P., Sonstein, J., Curtis, J. L. (2004). Specific Engagement of TLR4 or TLR3 Does Not Lead to IFN-{beta}-Mediated Innate Signal Amplification and STAT1 Phosphorylation in Resident Murine Alveolar Macrophages. J. Immunol. 173: 1033-1042 [Abstract] [Full Text]  
  • Condos, R., Hull, F. P., Schluger, N. W., Rom, W. N., Smaldone, G. C. (2004). Regional Deposition of Aerosolized Interferon-{gamma} in Pulmonary Tuberculosis. Chest 125: 2146-2155 [Abstract] [Full Text]  
  • Hoshino, Y., Tse, D. B., Rochford, G., Prabhakar, S., Hoshino, S., Chitkara, N., Kuwabara, K., Ching, E., Raju, B., Gold, J. A., Borkowsky, W., Rom, W. N., Pine, R., Weiden, M. (2004). Mycobacterium tuberculosis-Induced CXCR4 and Chemokine Expression Leads to Preferential X4 HIV-1 Replication in Human Macrophages. J. Immunol. 172: 6251-6258 [Abstract] [Full Text]  
  • Raju, B., Hoshino, Y., Kuwabara, K., Belitskaya, I., Prabhakar, S., Canova, A., Gold, J. A., Condos, R., Pine, R. I., Brown, S., Rom, W. N., Weiden, M. D. (2004). Aerosolized Gamma Interferon (IFN-{gamma}) Induces Expression of the Genes Encoding the IFN-{gamma}-Inducible 10-Kilodalton Protein but Not Inducible Nitric Oxide Synthase in the Lung during Tuberculosis. Infect. Immun. 72: 1275-1283 [Abstract] [Full Text]  
  • Gold, J. A., Hoshino, Y., Tanaka, N., Rom, W. N., Raju, B., Condos, R., Weiden, M. D. (2004). Surfactant Protein A Modulates the Inflammatory Response in Macrophages during Tuberculosis. Infect. Immun. 72: 645-650 [Abstract] [Full Text]